Damora Q2 net loss widens to $31.17 million
DMRA•Lead program enters Phase 1/1b trial
Damora said it recently initiated a Phase 1/1b trial of lead candidate DMR-001, targeting proof-of-concept readouts starting mid-2027.
Quarterly loss widens as expenses rise
Damora posted a GAAP net loss of $31.17 million for the quarter ended June 30, 2026, widening from $3.44 million a year earlier.
Operating loss widened to $34.99 million from $3.42 million, as operating expenses climbed to $34.99 million.
R&D expense rose to $25.54 million from $1.47 million, while G&A costs increased to $9.45 million from $1.96 million.
Other income swung to $4.08 million from a loss of $12,000, driven by higher interest income following recent financings.
Related News
Babcock & Wilcox publishes investor presentation on AI data center power solutions, coal and gas generation pipeline
BW•
Global Markets-Oil prices rally, Wall Street retreats with Hormuz, inflation in focus
SPY•
